Clinical Characteristics of Recipients of SBA−E− BMT
| . | Unrelated . | Related . | ||
|---|---|---|---|---|
| Adults (n = 32) . | Children (n = 30) . | Adults (n = 142) . | Children (n = 12) . | |
| Male/female | 14/18 | 18/12 | 77/65 | 9/3 |
| Age | ||||
| Median | 37.8 | 12.0 | 41.1 | 14.0 |
| Range | 19.7-58.9 | 2.13-18.1 | 18.0-69.2 | 4.15-19 |
| Diagnosis | ||||
| Acute leukemia | 4 (12.5) | 23 (76) | 60 (42) | 10 (83) |
| ALL | 3 | 14 | 11 | 6 |
| AML | 1 | 7 | 47 | 4 |
| Biphenotypic | 0 | 2 | 1 | |
| CML | 16 (50) | 3 (10) | 55 (38) | 0 (0) |
| NHL | 2 | 0 | 17 | 1 |
| Multiple myeloma | 0 | 0 | 5 | 0 |
| AA | 1 | 1 | 1 | 0 |
| MDS | 8 | 2 | 5 | 1 |
| Myelofibrosis | 1 | 0 | 0 | 0 |
| FEL | 0 | 1 | 0 | 1 |
| CMV status | ||||
| Patient/donor | ||||
| Neg/neg | 44% | 46% | 27% | 42% |
| Neg/pos | 9% | 13% | 15% | 0% |
| Pos/neg | 40% | 23% | 17% | 42% |
| Pos/pos | 6% | 17% | 41% | 17% |
| . | Unrelated . | Related . | ||
|---|---|---|---|---|
| Adults (n = 32) . | Children (n = 30) . | Adults (n = 142) . | Children (n = 12) . | |
| Male/female | 14/18 | 18/12 | 77/65 | 9/3 |
| Age | ||||
| Median | 37.8 | 12.0 | 41.1 | 14.0 |
| Range | 19.7-58.9 | 2.13-18.1 | 18.0-69.2 | 4.15-19 |
| Diagnosis | ||||
| Acute leukemia | 4 (12.5) | 23 (76) | 60 (42) | 10 (83) |
| ALL | 3 | 14 | 11 | 6 |
| AML | 1 | 7 | 47 | 4 |
| Biphenotypic | 0 | 2 | 1 | |
| CML | 16 (50) | 3 (10) | 55 (38) | 0 (0) |
| NHL | 2 | 0 | 17 | 1 |
| Multiple myeloma | 0 | 0 | 5 | 0 |
| AA | 1 | 1 | 1 | 0 |
| MDS | 8 | 2 | 5 | 1 |
| Myelofibrosis | 1 | 0 | 0 | 0 |
| FEL | 0 | 1 | 0 | 1 |
| CMV status | ||||
| Patient/donor | ||||
| Neg/neg | 44% | 46% | 27% | 42% |
| Neg/pos | 9% | 13% | 15% | 0% |
| Pos/neg | 40% | 23% | 17% | 42% |
| Pos/pos | 6% | 17% | 41% | 17% |